1-6 of 6
Huixian Hu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Easix Score Predicts Overall Survival and Non-Relapse Mortality in Elderly Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation

Lizhen Liu, Shipei Xiang, Xiaoyu Lai, Jimin Shi, Yanmin Zhao, Jian Yu, Ying Lu, Peipei Ye, Guifang Ouyang, Baodong Ye, Jianping Lan, Pengfei Shi, Haowen Xiao, Huarui Fu, Luxin Yang, Yishan Ye, Yi Chen, Yu Zhang, Yang Xu, Huixian Hu, Huifang Jiang, Yamin Tan, He Huang, Yi Luo
Journal: Blood
Blood (2024) 144 (Supplement 1): 2171.
https://doi.org/10.1182/blood-2024-212040
Published: 2024
Journal Articles

Impact of TP53 Allelic State on Outcomes of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasm

Bingqian Jiang, Tingting Yang, Yi Luo, Yanmin Zhao, Guifang Ouyang, Jian Yu, Jianping Lan, Ying Lu, Xiaoyu Lai, Baodong Ye, Yi Chen, Lizhen Liu, Yang Xu, Pengfei Shi, Haowen Xiao, Huixian Hu, Qunyi Guo, Huarui Fu, Yishan Ye, Xinyu Wang, Jie Sun, Weiyan Zheng, Jingsong He, Yi Zhao, Wenjun Wu, Zhen Cai, Guoqing Wei, He Huang, Jimin Shi
Journal: Blood
Blood (2023) 142 (Supplement 1): 2228.
https://doi.org/10.1182/blood-2023-184668
Published: 2023
Journal Articles

IPSS-M Predicts Survival Outcomes Significantly Better Than IPSS-R in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasms

Tingting Yang, Bingqian Jiang, Yi Luo, Yanmin Zhao, Guifang Ouyang, Jian Yu, Jianping Lan, Ying Lu, Xiaoyu Lai, Baodong Ye, Yi Chen, Lizhen Liu, Yang Xu, Qunyi Guo, Pengfei Shi, Haowen Xiao, Huixian Hu, Huarui Fu, Yishan Ye, Xinyu Wang, Jie Sun, Weiyan Zheng, Jingsong He, Yi Zhao, Wenjun Wu, Zhen Cai, Guoqing Wei, He Huang, Jimin Shi
Journal: Blood
Blood (2023) 142 (Supplement 1): 3579.
https://doi.org/10.1182/blood-2023-189068
Published: 2023
Journal Articles

Updated Results of a Prospective Study: Rituximab and Lenalidomide Plus Chidamide (RLC) for Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma

Cong Li, Huixian HU, Tao Lei, Haifeng Yu, Xi Chen, Shuailing Peng, Shuiyun Han, Haiyan Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6221.
https://doi.org/10.1182/blood-2023-184830
Published: 2023
Journal Articles

Interim Results of a Phase II Study of Dasatinib and Prednisone As an Oral, Chemo-Free Induction and Consolidation Regimen for Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Mixue Xie, Ying Lu, Guifang Ouyang, Liming Zhang, Huixian Hu, Ting Shi, Xueying Li, Xiujing Ye, Jie Jin, Hong-Hu Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 4402.
https://doi.org/10.1182/blood-2021-152554
Published: 2021
Journal Articles

Efficacy and Safety of Chidamide Combined with Thalidomide, Cyclophosphamide, and Dexamethasone (TC2D) As a Novel Oral Quadruplet Regimen for the Treatment of Relapsed/Refractory Multiple Myeloma: Initial Results of a Phase IIa, Multicenter Clinical Trial

Yi Li, Jingsong He, Xiaoyan Han, Gaofeng Zheng, Enfan Zhang, Qingxiao Chen, Donghua He, Yi Zhao, Jiaping Fu, Lihong Shou, Wenhua Jiang, Wei Jiang, Shenxian Qian, Huixian Hu, He Huang, Zhen Cai
Journal: Blood
Blood (2021) 138 (Supplement 1): 4761.
https://doi.org/10.1182/blood-2021-149188
Published: 2021